Results 211 to 220 of about 166,181 (302)

Pharmacodynamic Effects of Litifilimab in Lupus in a Randomized, Placebo-Controlled Phase 2 Study: Rapid and Sustained Reductions in Type I Interferon-Associated Gene Expression and Cytokines. [PDF]

Arthritis Rheumatol
Furie R, Werth VP, Milliman E, Ferber K, Brown R, Zoghbi J, Franchimont N, Lahoud Y, Barbey C.   +8 more
europepmc   +1 more source

Update on cutaneous lupus erythematosus

Indian Journal of Dermatology, Venereology, and Leprology, 2012
openaire   +2 more sources

Podocyte infolding glomerulopathy in a Japanese girl with systemic lupus erythematosus. [PDF]

CEN Case Rep
Watanabe S, Imon M, Ebara M, Kensuke J, Eguchi M.   +4 more
europepmc   +1 more source

Real-World Use of Anifrolumab for Articular Involvement in Systemic Lupus Erythematosus: A Monocentric Case Series and Systematic Review. [PDF]

J Pers Med
Cassone G, Santoro F, Nuara M, Cabassi C, Vacchi C, Secchi O, Giuggioli D.   +6 more
europepmc   +1 more source

Focus on Interferon Signature in Cutaneous Lupus Erythematosus: Novel Therapies From Better Understanding of the Pathogenesis. [PDF]

J Immunol Res
Gao M, Zhang N, Xia Y.
europepmc   +1 more source

Practical insights for the clinical implementation of the EULAR recommendations for patients with systemic lupus erythematosus. [PDF]

RMD Open
Parodis I, Fanouriakis A, Bortoluzzi A, Iking-Konert C, Weinmann-Menke J, San Román C, Levy RA, Rua-Figueroa I, Alexander T, Amoura Z.   +9 more
europepmc   +1 more source

Bridging Decades in Cutaneous Immunology-Past Lessons, Present Insights, Future Directions. [PDF]

Biomedicines
Simionescu O.
europepmc   +1 more source

Erbium-doped nonablative fractional laser therapy for postinflammatory hyperpigmentation and atrophic scarring due to discoid lupus erythematosus in a patient with systemic lupus erythematosus. [PDF]

JAAD Case Rep
Acevedo-Fontanez LA, Anshelevich E, Kim YJ, Shayegan L, Mortelliti C, Vleugels RA, Shahriari N.   +6 more
europepmc   +1 more source

Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions. [PDF]

Front Immunol
Kalyniuk K, Fetter T, Grützbach M, Guel T, Novak N, Wenzel J.   +5 more
europepmc   +1 more source